Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries

The outcome of acute myeloid leukemia patients aged 70 years or older is poor. Defining the best treatment option remains controversial especially when choosing between intensive chemotherapy and hypomethylating agents. We set up a multicentric European database collecting data of 3 700 newly diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Récher, Christian, Röllig, Christoph, Bérard, Emilie, Bertoli, Sarah, Dumas, Pierre-Yves, Tavitian, Suzanne, Kramer, Michael, Serve, Hubert, Bornhäuser, Martin, Platzbecker, Uwe, Müller-Tidow, Carsten, Baldus, Claudia D., Martínez-Cuadrón, David, Serrano, Josefina, Martínez-Sánchez, Pilar, Arbolí, Eduardo Rodríguez, Gil, Cristina, Bergua, Juan, Bernal, Teresa, de la Fuente Burguera, Adolfo, Delabesse, Eric, Bidet, Audrey, Pigneux, Arnaud, Montesinos, Pau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979811/
https://www.ncbi.nlm.nih.gov/pubmed/34775483
http://dx.doi.org/10.1038/s41375-021-01425-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979811/
https://www.ncbi.nlm.nih.gov/pubmed/34775483
http://dx.doi.org/10.1038/s41375-021-01425-9

Ejemplares similares